Index by Author

October 1993; 3 (2)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Atchison, B

    • Degradation of DNA during the denaturation step of PCR. Genome Res. October 1993 3: 133-134; doi:10.1101/gr.3.2.133

B

  1. Baas, P D

  2. Beier, F

    • Determination of 5' ends of specific mRNAs by DNA ligase-dependent amplification. Genome Res. October 1993 3: 95-99; doi:10.1101/gr.3.2.95

  3. Beldjord, C

    • Use of chemical clamps in denaturing gradient gel electrophoresis: application in the detection of the most frequent Mediterranean beta-thalassemic mutations. Genome Res. October 1993 3: 122-124; doi:10.1101/gr.3.2.122

  4. Beldjord, K

    • Use of chemical clamps in denaturing gradient gel electrophoresis: application in the detection of the most frequent Mediterranean beta-thalassemic mutations. Genome Res. October 1993 3: 122-124; doi:10.1101/gr.3.2.122

  5. Bertling, W M

    • Determination of 5' ends of specific mRNAs by DNA ligase-dependent amplification. Genome Res. October 1993 3: 95-99; doi:10.1101/gr.3.2.95

  6. Bienvenu, T

    • Use of chemical clamps in denaturing gradient gel electrophoresis: application in the detection of the most frequent Mediterranean beta-thalassemic mutations. Genome Res. October 1993 3: 122-124; doi:10.1101/gr.3.2.122

  7. Bos, J L

  8. Boyd, C D

    • Quantitation of tropoelastin mRNA and assessment of alternative splicing in human skin fibroblasts by reverse transcriptase-polymerase chain reaction. Genome Res. October 1993 3: 107-114; doi:10.1101/gr.3.2.107

C

  1. Caetano-Anollés, G

    • Amplifying DNA with arbitrary oligonucleotide primers. Genome Res. October 1993 3: 85-94; doi:10.1101/gr.3.2.85

  2. Chen, D

    • Controls for validation of relative reverse transcription--polymerase chain reaction assays. Genome Res. October 1993 3: 127-129; doi:10.1101/gr.3.2.127

D

  1. Deak, S B

    • Quantitation of tropoelastin mRNA and assessment of alternative splicing in human skin fibroblasts by reverse transcriptase-polymerase chain reaction. Genome Res. October 1993 3: 107-114; doi:10.1101/gr.3.2.107

  2. Desclaux Arramond, F

    • Use of chemical clamps in denaturing gradient gel electrophoresis: application in the detection of the most frequent Mediterranean beta-thalassemic mutations. Genome Res. October 1993 3: 122-124; doi:10.1101/gr.3.2.122

  3. Dieffenbach, C W

  4. Diener, U

    • Modified ASRA facilitates the characterization of activating point mutations in tumors, in which cancer cells constitute only a minor part of the investigated tissue. Genome Res. October 1993 3: 125-126; doi:10.1101/gr.3.2.125

  5. Douglas, A

    • Degradation of DNA during the denaturation step of PCR. Genome Res. October 1993 3: 133-134; doi:10.1101/gr.3.2.133

  6. Dragon, Elizabeth A.

    • Handling Reagents tn the PCR Laboratory Genome Res. October 1993 3: S8-S9; doi:10.1101/gr.3.2.S8

  7. Dudley, N

    • Modified ASRA facilitates the characterization of activating point mutations in tumors, in which cancer cells constitute only a minor part of the investigated tissue. Genome Res. October 1993 3: 125-126; doi:10.1101/gr.3.2.125

  8. Dveksler, G S

F

  1. Fernandez, E

    • Use of chemical clamps in denaturing gradient gel electrophoresis: application in the detection of the most frequent Mediterranean beta-thalassemic mutations. Genome Res. October 1993 3: 122-124; doi:10.1101/gr.3.2.122

H

  1. Hartley, J L

    • Dealing with contamination: enzymatic control of carryover contamination in PCR. Genome Res. October 1993 3: S10-S14; doi:10.1101/gr.3.2.S10

  2. Herzog, C P

    • Quantitation of tropoelastin mRNA and assessment of alternative splicing in human skin fibroblasts by reverse transcriptase-polymerase chain reaction. Genome Res. October 1993 3: 107-114; doi:10.1101/gr.3.2.107

  3. Holzenberger, M

    • Quantitation of tropoelastin mRNA and assessment of alternative splicing in human skin fibroblasts by reverse transcriptase-polymerase chain reaction. Genome Res. October 1993 3: 107-114; doi:10.1101/gr.3.2.107

J

  1. Jafari, M

    • Modified ASRA facilitates the characterization of activating point mutations in tumors, in which cancer cells constitute only a minor part of the investigated tissue. Genome Res. October 1993 3: 125-126; doi:10.1101/gr.3.2.125

K

  1. Kanno, T

    • Search for improved electrophoretic conditions for PCR--single-strand conformation polymorphism analysis: is an SDS buffer condition useful. Genome Res. October 1993 3: 130-132; doi:10.1101/gr.3.2.130

  2. Kaplan, J C

    • Use of chemical clamps in denaturing gradient gel electrophoresis: application in the detection of the most frequent Mediterranean beta-thalassemic mutations. Genome Res. October 1993 3: 122-124; doi:10.1101/gr.3.2.122

  3. Klebe, R J

    • Controls for validation of relative reverse transcription--polymerase chain reaction assays. Genome Res. October 1993 3: 127-129; doi:10.1101/gr.3.2.127

L

  1. Levi-Minzi, S A

    • Quantitation of tropoelastin mRNA and assessment of alternative splicing in human skin fibroblasts by reverse transcriptase-polymerase chain reaction. Genome Res. October 1993 3: 107-114; doi:10.1101/gr.3.2.107

M

  1. Maekawa, M

    • Search for improved electrophoretic conditions for PCR--single-strand conformation polymorphism analysis: is an SDS buffer condition useful. Genome Res. October 1993 3: 130-132; doi:10.1101/gr.3.2.130

  2. Mansfield, E S

    • Use of a sensitive fluorescent intercalating dye to detect PCR products of low copy number and high molecular weight. Genome Res. October 1993 3: 115-119; doi:10.1101/gr.3.2.115

O

  1. Ohler, L D

    • Use of a sensitive fluorescent intercalating dye to detect PCR products of low copy number and high molecular weight. Genome Res. October 1993 3: 115-119; doi:10.1101/gr.3.2.115

P

  1. Papp, T

    • Modified ASRA facilitates the characterization of activating point mutations in tumors, in which cancer cells constitute only a minor part of the investigated tissue. Genome Res. October 1993 3: 125-126; doi:10.1101/gr.3.2.125

R

  1. Rashtchian, A

    • Dealing with contamination: enzymatic control of carryover contamination in PCR. Genome Res. October 1993 3: S10-S14; doi:10.1101/gr.3.2.S10

  2. Reichenberger, E

    • Determination of 5' ends of specific mRNAs by DNA ligase-dependent amplification. Genome Res. October 1993 3: 95-99; doi:10.1101/gr.3.2.95

  3. Robert, L

    • Quantitation of tropoelastin mRNA and assessment of alternative splicing in human skin fibroblasts by reverse transcriptase-polymerase chain reaction. Genome Res. October 1993 3: 107-114; doi:10.1101/gr.3.2.107

  4. Rose, E A

    • Use of a sensitive fluorescent intercalating dye to detect PCR products of low copy number and high molecular weight. Genome Res. October 1993 3: 115-119; doi:10.1101/gr.3.2.115

S

  1. Saha, B K

  2. Schiffmann, D

    • Modified ASRA facilitates the characterization of activating point mutations in tumors, in which cancer cells constitute only a minor part of the investigated tissue. Genome Res. October 1993 3: 125-126; doi:10.1101/gr.3.2.125

  3. Sell, K W

  4. Shanmugam, V

  5. Sudo, K

    • Search for improved electrophoretic conditions for PCR--single-strand conformation polymorphism analysis: is an SDS buffer condition useful. Genome Res. October 1993 3: 130-132; doi:10.1101/gr.3.2.130

V

  1. van Weering, D H

Z

  1. Zollo, M

    • Use of a sensitive fluorescent intercalating dye to detect PCR products of low copy number and high molecular weight. Genome Res. October 1993 3: 115-119; doi:10.1101/gr.3.2.115

Current Issue

  1. February 2026, 36 (2)
  1. Current Issue
  1. Alert me to new issues of Genome Research